insights_auto
Why is RMD up 2.04%?
Dive Deeperchevron_right
RMD:ASX
Resmed CDI
A$32.55
arrow_upward
+2.04%(+0.65) 1D
Oct 8, 4:10:19 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for RMD...
Open
A$32.33
High
A$32.61
Low
A$32.33
Mkt. cap
31.78B
Avg. vol.
1.04M
Volume
785.94K
52-wk high
A$43.29
52-wk low
A$25.50
Shares outstanding
140.64M
No. of employees
11K
Open
A$32.33
High
A$32.61
Low
A$32.33
Mkt. cap
31.78B
Avg. vol.
1.04M
Volume
785.94K
52-wk high
A$43.29
52-wk low
A$25.50
Shares outstanding
140.64M
No. of employees
11K
News stories
From web sources and news partners
AD HOC NEWS
·
2 hours ago
Michael Farrell proposes 4,991-share sale in ResMed stock
www.intelligentinvestor.com.au
·
9 hours ago
CITIWARRANTS 8.1848 RMD MINI LONG (ASX:RMDKOE)
Stock Titan
·
15 hours ago
Michael Farrell proposes selling 4,991 ResMed (NYSE: RMD) shares through Fidelity.
Profile
Resmed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease, and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19. Resmed also provides software to out-of-hospital care agencies to streamline transitions of care into and between these care settings for seniors and their care providers.
Resmed employs more than 8,000 people worldwide as of June 2022. The company operates in more than 140 countries worldwide, and has manufacturing facilities in Australia, Singapore, France, and the United States. Revenue was US$4.7 billion in fiscal year 2024. Wikipedia
About Resmed CDI
CEOMichael J. Farrell
Employees11.4K
FoundedJun 1989
HeadquartersSan Diego, California, United States
SectorMedical device
Websiteresmed.com